Page last updated: 2024-10-17

salicylic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

salicylic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 5 studies

Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research Excerpts

ExcerptRelevanceReference
"A 67-year-old patient with chronic myeloid leukemia for 4 years rapidly developed multiple squamous-cell carcinomas on the scalp."1.29Multiple squamous-cell carcinomas of the scalp and chronic myeloid leukemia. ( Andrac, L; Angeli-Besson, C; Jacquet, P; Koeppel, MC; Sayag, J, 1995)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, A1
Hattori, M1
Takeuchi, Y1
Ishikawa, O1
Schmid-Wendtner, MH1
Wendtner, CM1
Stagno, F1
Vigneri, P1
Del Fabro, V1
Stella, S1
Restuccia, N1
Giallongo, C1
Massimino, M1
Berretta, S1
Pennisi, MS1
Tibullo, D1
TirrĂ², E1
Buscarino, C1
Messina, A1
Di Raimondo, F1
Farrell, SA1
Warda, LJ1
LaFlair, P1
Szymonowicz, W1
Angeli-Besson, C1
Koeppel, MC1
Jacquet, P1
Andrac, L1
Sayag, J1

Other Studies

5 other studies available for salicylic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Generalized keratosis pilaris-like eruptions in a chronic myelogenous leukemia patient treated with nilotinib.
    The Journal of dermatology, 2016, Volume: 43, Issue:9

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Drug Eruptions; Female; Fusion Proteins, bcr

2016
Intensified inflammatory reaction of actinic keratoses after single application of topical 5-fluorouracil in a patient treated with nilotinib for chronic myeloid leukemia.
    Dermatology (Basel, Switzerland), 2009, Volume: 219, Issue:4

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Dermatologic Agents; Drug Therapy, Combinati

2009
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothera

2010
Adams-Oliver syndrome: a case with juvenile chronic myelogenous leukemia and chylothorax.
    American journal of medical genetics, 1993, Dec-01, Volume: 47, Issue:8

    Topics: Chylothorax; Heart Defects, Congenital; Humans; Infant, Newborn; Leukemia, Myelogenous, Chronic, BCR

1993
Multiple squamous-cell carcinomas of the scalp and chronic myeloid leukemia.
    Dermatology (Basel, Switzerland), 1995, Volume: 191, Issue:4

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydr

1995